Pharmacy Update
Disclaimer: We are getting frequent COVID-related questions about drug concerns and potential interactions. This information is as of June 18, 2020. We will do our best to keep you up to date with this ever evolving situation. This is the most update information at the time of publication.
Note: There are no Food and Drug Administration
(FDA) approved therapies for treatment or prevention of COVID-19. If at all possible, it is best to have patients enrolled in a clinical trial.
In this issue:
DEXAMETHASONE – PRELIMINARY DATA COVID-19 MORTALITY BENEFIT -
Initial data from the low dose steroid arm of the United Kingdom based RECOVERY (Randomized Evaluation of COVID-19 thERapY) trial was released in a press release June 16, 2020.
HIGH DOSE ORAL ASCORBIC ACID AND ZINC GLUCONATE SUPPLEMENTATION (COVIDAtoZ) FOR COVID-19 -
A randomized single center, prospective, open label four arm study (NCT04342728),
1
sponsored by the Cleveland Clinic, is currently inviting participants 18 years or older who have received a positive test for COVID-19 and are being managed in an outpatient setting to enroll in their clinical study.
